期刊文献+

cyclinD1、p16、cyclinA1在瘢痕疙瘩和增生性瘢痕中的表达及意义 被引量:2

Expression and significance of cyclinD1,p16 and cyclinA1 in keloids and hypertrophic scars
下载PDF
导出
摘要 目的:观察瘢痕疙瘩和增生性瘢痕中成纤维细胞的cyclinD1、p16和cyclinA1的表达,探讨其表达的差异与两种不同类型瘢痕的形成之间的关联性。方法:实验组分为瘢痕疙瘩和增生性瘢痕两组,以正常皮肤组织作为对照组,通过SP免疫组化检测两实验组中cyclinD1、p16和cyclinA1的表达。结果:cyclinD1在瘢痕疙瘩的阳性表达率为91.7%,显著高于增生性瘢痕组的45.5%以及对照组(P<0.05);P16在增生性瘢痕的阳性表达率为81.8%,显著高于瘢痕疙瘩组的33.3%以及对照组(P<0.05);cyclinA1在瘢痕疙瘩的阳性表达率为75.0%,显著高于增生性瘢痕组的27.3%(P<0.05);cyclinD1和cyclinA1在增生性瘢痕组的表达率以及P16在瘢痕疙瘩组的表达率均高于正常皮肤组,但统计学分析其差异并不明显。结论:在瘢痕的形成过程中,cyclinD1和p16作为一对细胞周期的正负调控因子和cyclinA1作为正调控因子的表达失衡对瘢痕的不同转归是重要的参与机制。 Objective:To investigate the expression of cyclinD1,P16 and cyelinAl in the fibroblasts of keloids and hypertrophic scars, and explore the relationship between the genesis of two different kinds of scars. Methods:Normal skin tissues were used as control group,and the expression of cyclinDl,pl6 and eyclinA1 were screened in hypertrophic scars and keloids by immunohisto- chemical SP method. Results:In keloids,positive expression rate of eyclinD1 is 91.7%, that obviously higher than 45.5% in the hypertrophic scar group as well as the control group (P 〈 0.05) ;81.8% as the positive rate of p16 in hypertrophic scar group is significant higher than the rate of keloid group,which is 33.3% as well as the control group (P 〈 0.05) ;the rate of cyclinA1 in keloids (75.0%) is higher than hypertrophic scar group (27.3%) as well as the control group(P 〈 0.05);cyclinD1 and cyclinA1 in hypertrophic scars, as well as the expression rate of P16 in the keloid group,are higher than that in the normal skin group,but the difference are not significant. Conclusion:In the progress of scar formation,the imbalance expressions of cyclinD1 and p16,as one pair of the positive and negative cell cycle regulatory factors and positive regulatory factor of cyclinA1, play important roles of the prognosis of scars.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2009年第8期1104-1107,共4页 Journal of Nanjing Medical University(Natural Sciences)
关键词 瘢痕疙瘩 增生性瘢痕 CYCLIND1 P16 cyclinA1 keloid hypertrophic scar cyclinD1 p16 cyclinA1
  • 相关文献

参考文献5

二级参考文献36

  • 1杨荣宁,邝国乾,罗元,莫立根,许坚,李淑兰,李伟,崔英.p16和Cyclin D1表达与鼻咽癌发生的相关性[J].中国耳鼻咽喉头颈外科,2004,11(5):323-325. 被引量:2
  • 2于冬梅,陈天新,吕松岑,韩竹.病理性瘢痕中p53和cyclinD_1的mRNA表达的实验研究[J].中国实用美容整形外科杂志,2005,16(2):74-76. 被引量:17
  • 3史立新,李钢,洪宝发,那彦群.肾细胞癌组织中CDK4、CyclinD1的表达及其意义[J].解放军医学杂志,2006,31(6):548-549. 被引量:3
  • 4[5]KONG S,AMOS C I,LUTHRA R,et al.Effects of cyclin D1 polymaorphism on age of onset of hereditary nonpolyposis colorectal cancer[J].Cancer Res,2000,60(2):2492-2521.
  • 5[7]REDDY H K,METTUS R V,RANE S G,et al.Cyclin-deendent kinase 4 expression is essential for neu-induced breast tumorigenesis[J].Cancer Res,2005,65(22):10174-10182.
  • 6[8]YANK X,LIU BC,SHI X L,et al.Role of cyclinD1 and CDK4 in the carcinogenesis induced by silica[J].Biomed Environ Sci,2005,18(5):286-297.
  • 7Resnitzky D,Hengst L,Reed S I,et al.Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in Gl by p27Kipl[J].Mol Cell Biol,1995,15(8) :4347-4352.
  • 8Stone S,Jiang P,Dayananth P,et al.Complex structure and regulation of the p16(MTS1)locus[J].J Cancer Res,1995,55:2988.
  • 9Cardo CC.Mutation of cell cycle regulaters [J].J Am J Path,1995,147:545.
  • 10Nakanishi M,Kagawa Y,Takahashi H,et al.Two different bindings of p21 Cdk inhibitor to cyclin/Cdk complex[J].Leukemia 1997,1 l(Suppl):356-357.

共引文献58

同被引文献59

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部